1. Date of change: 115/06/17 2. Name of functional committee: Audit Committee, Compensation Committee 3. Name of predecessor: (1) Audit Committee Independent Director: Chen Yi-Shih Independent Director: Lung Hui-Shih Independent Director: Lu Rui-Mei (2) Compensation Committee Independent Director: Chen Yi-Shih Independent Director: Lung Hui-Shih Independent Director: Lu Rui-Mei 4. Resume of predecessor: Chen Yi-Shih / Chairman and Chief Strategy Officer, Apacer Technology Inc. Lung Hui-Shih / Chairman, Hsiang Long Investment Co., Ltd. Lu Rui-Mei / Director, Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute 5. Name of successor: (1) Audit Committee Independent Director: Chen Yi-Shih Independent Director: Lung Hui-Shih Independent Director: Wu Bifen (2) Compensation Committee Independent Director: Chen Yi-Shih Independent Director: Lung Hui-Shih Independent Director: Wu Bifen 6. Resume of successor: Chen Yi-Shih / Chairman and Chief Strategy Officer, Apacer Technology Inc. Lung Hui-Shih / Chairman, Hsiang Long Investment Co., Ltd. Wu Bifen / Vice President, Asia Pacific, AbbVie Singapore 7. Situation of change: Expiration of term 8. Reason for change: Comprehensive re-election of directors 9. Former term: 112/06/14 ~ 115/06/13 10. Effective date of successor: 115/06/17 11. Other matters to be noted: None

FACT BOX

  • Source: PR Times
  • Category: 人事
  • Dates in source: 115/06/17 / 112/06/14~115/06/13